v3.26.1
Contract Balances and Performance Obligations
 3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Contract Balances and Performance Obligations Revenue
Disaggregation of Revenue
The following table represents Health Catalyst’s revenue disaggregated by type of arrangement (in thousands):
Three Months Ended March 31,
20262025
(unaudited)
Recurring technology$49,468 $51,482 
Professional services21,288 27,931 
Total revenue$70,756 $79,413 
Revenue related to contracts with clients located in the United States was 95.7% and 96.1% for the three months ended March 31, 2026 and 2025, respectively.
Contract Balances and Performance Obligations
As of March 31, 2026 and December 31, 2025, the unbilled accounts receivable included in accounts receivable on our consolidated balance sheets was $6.5 million and $10.1 million, respectively.
As of March 31, 2026 and December 31, 2025, the total of current and non-current deferred revenue on our consolidated balance sheets was $70.0 million and $56.5 million, respectively. Deferred revenue includes advance client payments and billings in excess of revenue recognized. For each of the three months ended March 31, 2026 and 2025, 39% and 34%, respectively, of the revenue recognized was included in deferred revenue at the beginning of the period.
Most of our technology and professional services contracts have a three- or five-year term, of which many are terminable after one year upon 90 days’ notice. For arrangements that do not allow the client to cancel within one year or less, we expect to recognize $244.2 million of revenue on unsatisfied performance obligations as of March 31, 2026. We expect to recognize approximately 70% of the remaining performance obligations over the next 24 months, with the balance recognized thereafter.